Document Detail


Corpus cavernosum dysfunction in diabetic rats: effects of combined alpha-lipoic acid and gamma-linolenic acid treatment.
MedLine Citation:
PMID:  11747143     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The effects of streptozotocin-induced diabetes on nitric oxide (NO)-mediated relaxation of rat corpus cavernosum smooth muscle to neurogenic and endothelial stimulation was examined. The aim was to assess the effects of treatment with low doses of the antioxidant, alpha-lipoic acid, and the omega-6 essential fatty acid, gamma-linolenic acid, either separately or in combination. METHODS: Treatment was preventive from diabetes induction or corrective over 4 weeks after 4 weeks of untreated diabetes. Corpus cavernosum responses were examined in vitro. RESULTS: Neither diabetes nor treatment affected contractile responses to transmural electrical field stimulation of noradrenergic nerves. Stimulation of phenylephrine precontracted cavernosa in the presence of guanethidine and atropine caused relaxation via the nitrergic innervation. Maximum relaxation responses were 40% and 46% decreased after 4 and 8 weeks of diabetes, respectively. alpha-Lipoic acid, gamma-linolenic acid combination treatment fully prevented this deficit, and partially (52%) corrected the effect of 4 weeks of untreated diabetes. Neither alpha-lipoic acid nor gamma-linolenic components alone had significant effects, which suggests that there were synergistic interactions between the drugs. Both 4 and 8 weeks of untreated diabetes reduced maximum endothelium-dependent relaxation of phenylephrine precontracted cavernosa to acetylcholine by approximately 40%. While alpha-lipoic acid or gamma-linolenic acid were ineffective, joint treatment fully prevented and corrected this diabetic endothelial deficit. Neither diabetes nor treatment affected endothelium-independent relaxation to the NO donor, sodium nitroprusside. CONCLUSION: The data show that alpha-lipoic acid and gamma-linolenic acid interact synergistically to improve NO-mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in experimental diabetes.
Authors:
A Keegan; M A Cotter; N E Cameron
Related Documents :
15284693 - Effect of fenugreek seeds on the fasting blood glucose level in the streptozotocin indu...
11467413 - Alterations in nitric oxide activity and sensitivity in early streptozotocin-induced di...
20444913 - Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays fo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diabetes/metabolism research and reviews     Volume:  17     ISSN:  1520-7552     ISO Abbreviation:  Diabetes Metab. Res. Rev.     Publication Date:    2001 Sep-Oct
Date Detail:
Created Date:  2001-12-17     Completed Date:  2002-01-31     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100883450     Medline TA:  Diabetes Metab Res Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  380-6     Citation Subset:  IM    
Copyright Information:
Copyright 2001 John Wiley & Sons, Ltd.
Affiliation:
Department of Biomedical Sciences, University of Aberdeen, Aberdeen, Scotland, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcholine / pharmacology
Animals
Antioxidants / therapeutic use*
Blood Glucose / analysis
Diabetes Mellitus, Experimental / complications*
Drug Therapy, Combination
Electric Stimulation
Erectile Dysfunction / drug therapy*,  etiology*
Male
Muscle Contraction / drug effects
Muscle Relaxation / drug effects
Muscle, Smooth / blood supply,  innervation,  physiopathology
Nitric Oxide / pharmacology
Nitric Oxide Donors / pharmacology
Nitroarginine / pharmacology
Nitroprusside / pharmacology
Penis / blood supply,  innervation
Phenylephrine / pharmacology
Rats
Rats, Sprague-Dawley
Thioctic Acid / administration & dosage,  therapeutic use*
gamma-Linolenic Acid / administration & dosage,  therapeutic use*
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Blood Glucose; 0/Nitric Oxide Donors; 10102-43-9/Nitric Oxide; 15078-28-1/Nitroprusside; 2149-70-4/Nitroarginine; 506-26-3/gamma-Linolenic Acid; 51-84-3/Acetylcholine; 59-42-7/Phenylephrine; 62-46-4/Thioctic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prospective study of diabetes mellitus and liver cancer in Japan.
Next Document:  Effects of acipimox on the lipolysis rate in subcutaneous adipose tissue of obese subjects.